News

Pharmabiz1h
Seminar on revised Schedule M at JIS University in Kolkata emphasizes urgent GMP compliance in Indian pharma
Peethaambaran Kunnathoor, Chennai Wednesday, July 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre
Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre: Gireesh Babu, New Delhi Wednesday, July 30, 2025, 08:00 Hrs [IST] The Schemes supporting develo ...
Pharmabiz1h
A culture of quality excipients has ushered in: Experts at IPEC India Annual Conference
A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...
Pharmabiz1h
DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China
DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China: Shardul Nautiyal, Mumbai Wednesday, July 30, 2025, 08:00 Hrs [IST] Aimed at safeguarding domestic indu ...
Pharmabiz1h
Indian nutraceutical companies grapple with a maze of global regulatory challenges
Indian nutraceutical companies grapple with a maze of global regulatory challenges: Nandita Vijayasimha, Bengaluru Wednesday, July 30, 2025, 08:00 Hrs [IST] Indian nutraceutical c ...
Pharmabiz17h
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC: Honk Kong Tuesday, July 29, 2025, 16:00 Hrs [IST] Akeso, Inc., ...
Pharmabiz16h
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore: Singapore Tuesday, July 29, 2025, 17:00 Hrs [IST] Elpis ...
Pharmabiz19h
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...
Pharmabiz18h
BPL Medical Technologies chief notes inking India-UK FTA to propel growth
BPL Medical Technologies chief notes inking India-UK FTA to propel growth: Our Bureau, Bengaluru Tuesday, July 29, 2025, 15:30 Hrs [IST] BPL Medical Technologies managing director ...
Pharmabiz18h
Advicenne receives marketing authorization and reimbursement status for Sibnayal in Kingdom of Saudi Arabia
Advicenne receives marketing authorization and reimbursement status for Sibnayal in Kingdom of Saudi Arabia: Paris, France Tuesday, July 29, 2025, 15:00 Hrs [IST] Advicenne, a pha ...
Pharmabiz21h
Tata Elxsi & KAVIA AI ink strategic pact, bringing GenAI powered SDLC automation to healthcare enterprises among others
Tata Elxsi & KAVIA AI ink strategic pact, bringing GenAI powered SDLC automation to healthcare enterprises among others: Our Bureau, Bengaluru Tuesday, July 29, 2025, 12:30 Hrs [I ...
Pharmabiz17h
Fortis and Agilus expand rapid genomic testing capabilities with launch of second Genexus System
Fortis and Agilus expand rapid genomic testing capabilities with launch of second Genexus System: Our Bureau, Bengaluru Tuesday, July 29, 2025, 16:15 Hrs [IST] Fortis Memorial Res ...